HIV prevention has advanced with lenacapavir, a yearly injection that blocks the virus's replication, providing long-term ...
Prof. Francisca Mutapi, a global health expert suggests 4 ways to end the dependence HEALTH | FRANCISCA MUTAPI | There’s been a global trend in the reduction of aid to Africa since 2018. Donors are ...
The United States’ shutdown of HIV/Aids funding may harm global Aids programmes irreparably, jeopardising millions of lives ...
Providing feedback following point-of-care urine testing for tenofovir concentrations was associated with increased PrEP ...
A new study in Australia found that treating male partners can reduce BV reinfections, suggesting that BV may be sexually ...
Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir ...
Merck's DOR/ISL met primary efficacy and safety goals in two Phase 3 HIV trials. Marketing applications are planned for ...
Newspoint on MSN17h
Get one injection in a year and get rid of the tension of HIV! It can be a boon for such peopleScientists have got success with a new injection of HIV. Taking this injection once a year can reduce the risk of HIV ...
New data from the MK-8591A-051 and MK-8591A-052 trials, both investigating the efficacy and safety of 100-mg doravirine and 0.25-mg islatravir as a once-daily 2-drug regimen for virologically ...
Measles is unlike other childhood viruses. In severe cases, it can cause pneumonia. About 1 in 1,000 patients develops encephalitis.
Incident HCV infection more than doubled among HIV-positive MSM with no history of injection drug use between 1995 and 2023.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback